Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 636-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects

By Farid N. A.   Jakubowski J. A.   Payne C. D.   Li Y. G.   Jin Y.   Ernest C. S.   Winters K. J.   Brandt J. T.   Salazar D. E.   Small D. S.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1821-1829

Informa Healthcare

Access to resources Recommend Favorite

Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial

By Sasaki Takashi   Seino Yutaka   Fukatsu Atsushi   Sakai Soichi   Samukawa Yoshishige  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 345-361

Springer Publishing Company

Access to resources Recommend Favorite

A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

By Wemer Johan   Cheng Yi-Fang   Nilsson Dag   Reinholdsson Ingalill   Fransson Bo   Lanbeck Vallén Kerstin   Nyman Lars   Eriksson Catarina   Björck Staffan   Schulman Sam  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1813-1823

Informa Healthcare

Access to resources Recommend Favorite